Abstract
Background
This study aimed to determine the prevalence of neuropathic pain (NeP) and fibromyalgia syndrome (FMS) in prediabetics and to compare them with normoglycemic controls, to disclose the impact of NeP and FMS in disease burden.
Methods
People, 18–65 years old, who were admitted to a tertiary hospital’s internal medicine outpatient clinic for routine health check-ups and then those who were newly diagnosed with prediabetes were recruited as a prediabetic group and those who were normoglycemic were recruited as a control group. Participants’ demographics and clinical data were recorded. The ShortForm-36 and Hospital Anxiety-Depression Scale were answered by the participants. The 2016 ACR Fibromyalgia Diagnostic Criteria and the painDETECT questionnaire were used for evaluation of FMS and NeP, respectively. One hundred nine prediabetics and 53 controls were enrolled.
Results
Eighty-four (77.1%) of 109 prediabetics and 37 of 53 controls (69.8%) were female. The mean age of the prediabetics was 48.85 (SD = 9.8) and the controls was 47.37 (SD = 11.11). Age, gender, BMI, smoking status, occupational, marital, and educational status were similar between the groups. FMS was more common in prediabetics 32 (29.6%) of 109 than in normoglycemics 7 (13.2 %) of 53 (p = 0.022). Eight of the prediabetics (7.4%) and 2 of the normoglycemics (3.8%) had possible or likely NeP (p = 0.273). The frequency of possible or likely NeP was higher in prediabetics with FMS than without FMS (p = 0.001). The prevalence of FMS was higher in prediabetics with NeP (87.5%) than without NeP (25.5%) (p = 0.001). Prediabetics with FMS or NeP had lower QoL than without FMS or NeP (p < 0.001, p = 0.014, respectively).
Conclusion
While evaluating prediabetics, it is important to assess both FMS and NeP.
Similar content being viewed by others
Data availability
Available.
Code availability
N/A.
References
Arnold LM, Bennett RM, Crofford LJ, Dean LE, Clauw DJ, Goldenberg DL, et al. AAPT diagnostic criteria for fibromyalgia. J Pain. 2019;20(6):611–28.
Lefaucheur JP. The “paradox” of neuropathic pain associated with small-fiber lesions in the context of fibromyalgia. Pain. 2016;157(6):1364–5.
Cheng CW, Wong CS, Hui GK, Chung EK, Wong SH. Fibromyalgia: is it a neuropathic pain? Pain Manag. 2018;8(5):377–88.
Ghavidel-Parsa B, Bidari A, Amir Maafi A, Ghalebaghi B. The iceberg nature of fibromyalgia burden: the clinical and economic aspects. Korean J Pain. 2015;28(3):169–76.
Stewart WF, Ricci JA, Chee E, Hirsch AG, Brandenburg NA. Lost productive time and costs due to diabetes and diabetic neuropathic pain in the US workforce. J Occup Environ Med. 2007;49(6):672–9.
Wolak T, Weitzman S, Harman-Boehm I, Friger M, Sukenik S. Prevalence of fibromyalgia in type 2 diabetes mellitus. Harefuah. 2001;140:1006–9 1119, 1120).
Tishler M, Smorodin T, Vazina-Amit M, Ramot Y, Koffler M, Fishel B. Fibromyalgia in diabetes mellitus. Rheumatol Int. 2003;23:171–3.
Mirghani HO, Elbadawi AS. Are diabetes mellitus, restless syndrome, and fibromyalgia related? Indian J Basic Appl Med Res. 2016;5:208–15.
Tugrul G, Coskun NC, Sarpel T, Sert M, Nazlican E. THU0559 frequency of fibromyalgia syndrome in patients with type 2 diabetes mellitus. Ann Rheum Dis. 2016;75(Suppl 2):394–394.
Yanmaz MN, Mert M, Korkmaz M. The prevalence of fibromyalgia syndrome in a group of patients with diabetes mellitus. Rheumatol Int. 2012;32:871–4.
Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A. Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: The MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care. 2008;31:464–9.
Daousi C, MacFarlane IA, Woodward A, Nurmikko TJ, Bundred PE, Benbow SJ. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med. 2004;21:976–82.
Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006;29:1518–22.
Wu EQ, Borton J, Said G, Le TK, Monz B, Rosilio M, et al. Estimated prevalence of peripheral neuropathy and associated pain in adults with diabetes in France. Curr Med Res Opin. 2007;23:2035–42.
American Diabetes Association. Standards of medical care in diabetes-2017. Diabetes Care. 2017;40:11–24.
Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A, KORA Study Group. Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA/KORA Augsburg Surveys S2 and S3. Pain Med. 2009;10(2):393–400.
World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i–xii 1-253.
Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio Heart Study. Diabetes Care. 1997;20(7):1087–92.
Aydemir O. Validity and reliability of Turkish version of hospital anxiety and depression scale. Turk J Psychiatry. 1997;8:280–7.
J Ware K Snow M Kosinski BG Gandek SF-36 health survey. Manual and interpretation guide Boston New England Medical Center, The Health Institute 1993
Haywood KL, Garratt AM, Fitzpatrick R. Quality of life in older people: a structured review of generic self-assessed health instruments. Qual Life Res. 2005;14(7):1651–68.
Çelik D, Çoban Ö. Short Form Health Survey version-2.0 Turkish (SF-36v2) is an efficient outcome parameter in musculoskeletal research. Acta Orthop Traumatol Turc. 2016;50(5):558–61.
Freynhagen R, Baron R, Gockel U, Tölle TR. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006;22(10):1911–20.
Alkan H, Ardic F, Erdogan C, Sahin F, Sarsan A, Findikoglu G. Turkish version of the pain-DETECT questionnaire in the assessment of neuropathic pain: a validity and reliability study. Pain Med. 2013;14(12):1933–43.
Wolfe F, Clauw DJ, Fitzcharles M-A, Goldenberg DL, Häuser W, Katz RL, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;46(3):319–29.
Sarmer S, Ergin S, Yavuzer G. The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int. 2000;20:9–12.
Häuser W, Ablin J, Fitzcharles MA, Littlejohn G, Luciano JV, Usui C, et al. Fibromyalgia. Nat Rev Dis Primers. 2015;1:15022 Review.
Kang JH, An M, Choi SE, Xu H, Park DJ, Lee JK, et al. Performance of the revised 2016 fibromyalgia diagnostic criteria in Korean patients with fibromyalgia. Int J Rheum Dis. 2019;22(9):1734–40.
Topbas M, Cakirbay H, Gulec H, Akgol E, Ak I, Can G. The prevalence of fibromyalgia in women aged 20–64 in Turkey. Scand J Rheumatol. 2005;34(2):140–4.
Ursini F, Naty S, Grembiale RD. Fibromyalgia and obesity: the hidden link. Rheumatol Int. 2011;31(11):1403–8.
Branco JC, Bannwarth B, Failde I, AbelloCarbonell J, Blotman F, Spaeth M, et al. Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum. 2010;39(6):448–53.
Kowall B, Lehnich AT, Strucksberg KH, Führer D, Erbel R, Jankovic N, et al. Associations among sleep disturbances, nocturnal sleep duration, daytime napping, and incident prediabetes and type 2 diabetes: the Heinz Nixdorf Recall Study. Sleep Med. 2016;21:35–41.
Brannick B, Dagogo-Jack S. Prediabetes and cardiovascular disease: pathophysiology and interventions for prevention and risk reduction. Endocrinol Metab Clin North Am. 2018;47(1):33–50.
Murnion BP. Neuropathic pain: current definition and review of drug treatment. Aust Prescr. 2018;41(3):60–3.
Fischer TZ, Waxman SG. Neuropathic pain in diabetes—evidence for a central mechanism. Nat Rev Neurol. 2010;6(8):462–6.
Girach A, Julian TH, Varrassi G, Paladini A, Vadalouka A, Zis P. Quality of life in painful peripheral neuropathies: a systematic review. Pain Res Manag. 2019;23(2019):2091960.
Gok K, Cengiz G, Erol K, Ozgocmen S. Neuropathic pain component in axial spondyloarthritis and the influence on disease burden. J Clin Rheumatol. 2018;24(6):324–7.
Cengiz G, Erol K, Gok K, Ozgocmen S. Comparison of pain characteristics in patients with rheumatoid arthritis and systemic sclerosis with particular reference to the neuropathic pain component: cross-sectional study. Med Princ Pract. 2018;27(6):537–42.
Degu H, Wondimagegnehu A, Yifru YM, Belachew A. Is health related quality of life influenced by diabetic neuropathic pain among type II diabetes mellitus patients in Ethiopia? PLoS One. 2019;14(2):e0211449.
Olmez N, Degirmenci Y, Kececi H. Effects of pain and disability on quality of life in patients with diabetic polyneuropathy. Neurosci Med. 2015;6:98–106.
International Association for the Study of Pain. IASP Taxonomy. Pain terms. Neuropathic pain. Updated 2017 Dec 14. https://www.iasp-pain.org/Education/Content.aspx?ItemNumber=1698&navItemNumber=576#Neuropathicpain.
Kösehasanoğullari M, ErdinçGündüz N, Akalin E. Is fibromyalgia syndrome a neuropathic pain syndrome? Arch Rheumatol. 2018;34(2):196–203.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection, and analyses were performed by all authors. The first draft of the manuscript was written by KE and all authors commented on previous versions of the manuscript.
Corresponding author
Ethics declarations
Ethics approval
Erciyes University Local Ethical Committee approval was received (Date: 20.02.2019; No: 2019/141).
Consent to participate
This study was performed in accordance with the Declaration of Helsinki and Good Clinical Practice. The patient’s written informed consent to publish the clinical information and materials was obtained.
Consent for publication
All authors have seen and approved the revised manuscript for publication.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This paper was not presented anywhere
Rights and permissions
About this article
Cite this article
Erol, K., Topaloğlu, U.S. Two nested syndromes: fibromyalgia and neuropathic pain in prediabetes—a pilot study. Int J Diabetes Dev Ctries 42, 261–268 (2022). https://doi.org/10.1007/s13410-021-00961-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13410-021-00961-5